Shares of Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report) shot up 17.7% on Monday . The stock traded as high as $88.24 and last traded at $88.24. 4,000 shares were traded during trading, an increase of 725% from the average session volume of 485 shares. The stock had previously closed at $75.00.
Pharma Mar Price Performance
The company has a debt-to-equity ratio of 0.14, a current ratio of 2.55 and a quick ratio of 2.01. The business’s 50-day simple moving average is $79.78 and its two-hundred day simple moving average is $60.89.
Pharma Mar Company Profile
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
Featured Articles
- Five stocks we like better than Pharma Mar
- How to Find Undervalued Stocks
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- What is a SEC Filing?
- 3 Steel Stocks Soaring After Tariff Announcements
- What is a Special Dividend?
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
